Found: 21
Select item for more details and to access through your institution.
Anticoagulation against portal vein thrombosis reduces mortality and liver cirrhosis‐related complications: A propensity score‐matched study.
- Published in:
- Hepatology Research, 2023, v. 53, n. 11, p. 1096, doi. 10.1111/hepr.13942
- By:
- Publication type:
- Article
Impact of novel NS5A resistance-associated substitutions of hepatitis C virus detected in treatment-experienced patients.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-42114-z
- By:
- Publication type:
- Article
LIM homeobox 2 promotes interaction between human iPS-derived hepatic progenitors and iPS-derived hepatic stellate-like cells.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37430-9
- By:
- Publication type:
- Article
Time course alterations of virus sequences and immunoglobulin titers in a chronic hepatitis E patient.
- Published in:
- Hepatology Research, 2020, v. 50, n. 4, p. 524, doi. 10.1111/hepr.13480
- By:
- Publication type:
- Article
Comprehensive genetic analysis of cholangiolocellular carcinoma with a coexistent hepatocellular carcinoma‐like area and metachronous hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2019, v. 49, n. 12, p. 1466, doi. 10.1111/hepr.13403
- By:
- Publication type:
- Article
Association of serum interferon‐λ3 levels with hepatocarcinogenesis in chronic hepatitis C patients treated with direct‐acting antiviral agents.
- Published in:
- Hepatology Research, 2019, v. 49, n. 5, p. 500, doi. 10.1111/hepr.13307
- By:
- Publication type:
- Article
ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin.
- Published in:
- Hepatology Research, 2017, v. 47, n. 11, p. 1212, doi. 10.1111/hepr.12867
- By:
- Publication type:
- Article
Bone morphogenetic protein-4 modulates proliferation and terminal differentiation of fetal hepatic stem/progenitor cells.
- Published in:
- Hepatology Research, 2017, v. 47, n. 9, p. 941, doi. 10.1111/hepr.12823
- By:
- Publication type:
- Article
Efficacy of additional radiofrequency ablation after transcatheter arterial chemoembolization for intermediate hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2016, v. 46, n. 4, p. 312, doi. 10.1111/hepr.12566
- By:
- Publication type:
- Article
Studies on virus kinetics using infectious fluorescence-tagged hepatitis C virus cell culture.
- Published in:
- Hepatology Research, 2011, v. 41, n. 3, p. 258, doi. 10.1111/j.1872-034X.2010.00771.x
- By:
- Publication type:
- Article
ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C N. Sakamoto et al. ITPA gene variant against anemia.
- Published in:
- Hepatology Research, 2010, v. 40, n. 11, p. 1063, doi. 10.1111/j.1872-034X.2010.00741.x
- By:
- Publication type:
- Article
Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades.
- Published in:
- PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0297882
- By:
- Publication type:
- Article
Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus.
- Published in:
- Scientific Reports, 2016, p. 29358, doi. 10.1038/srep29358
- By:
- Publication type:
- Article
Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C.
- Published in:
- Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 6, p. 1075, doi. 10.1111/jgh.12902
- By:
- Publication type:
- Article
Diabetic Retinopathy as a Risk Factor Associated with the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
- Published in:
- Digestive Diseases, 2019, v. 37, n. 3, p. 247, doi. 10.1159/000493580
- By:
- Publication type:
- Article
Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs.
- Published in:
- Journal of Gastroenterology, 2020, v. 55, n. 10, p. 990, doi. 10.1007/s00535-020-01715-6
- By:
- Publication type:
- Article
Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection.
- Published in:
- Journal of Gastroenterology, 2010, v. 45, n. 6, p. 656, doi. 10.1007/s00535-009-0195-7
- By:
- Publication type:
- Article
Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells.
- Published in:
- Journal of Gastroenterology, 2010, v. 45, n. 5, p. 523, doi. 10.1007/s00535-009-0162-3
- By:
- Publication type:
- Article
Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
- Published in:
- Journal of Medical Virology, 2017, v. 89, n. 7, p. 1241, doi. 10.1002/jmv.24763
- By:
- Publication type:
- Article
Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b.
- Published in:
- Journal of Medical Virology, 2011, v. 83, n. 5, p. 871, doi. 10.1002/jmv.22038
- By:
- Publication type:
- Article